statistiche ricercatore

Continente	#
NA - Nord America	499
AS - Asia	302
EU - Europa	288
SA - Sud America	250
AF - Africa	19
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.359

Nazione	#
US - Stati Uniti d'America	478
BR - Brasile	226
SG - Singapore	131
DE - Germania	105
FI - Finlandia	73
CN - Cina	48
IT - Italia	43
VN - Vietnam	41
HK - Hong Kong	22
FR - Francia	16
CA - Canada	13
AR - Argentina	11
GB - Regno Unito	10
PL - Polonia	8
RU - Federazione Russa	8
BD - Bangladesh	7
ES - Italia	7
PK - Pakistan	7
IN - India	6
TR - Turchia	6
IQ - Iraq	5
JP - Giappone	5
MX - Messico	5
UY - Uruguay	4
UZ - Uzbekistan	4
VE - Venezuela	4
AE - Emirati Arabi Uniti	3
AZ - Azerbaigian	3
CZ - Repubblica Ceca	3
KE - Kenya	3
LT - Lituania	3
ZA - Sudafrica	3
AT - Austria	2
CO - Colombia	2
DZ - Algeria	2
EC - Ecuador	2
EG - Egitto	2
JM - Giamaica	2
JO - Giordania	2
KG - Kirghizistan	2
KR - Corea	2
MA - Marocco	2
MK - Macedonia	2
PS - Palestinian Territory	2
SN - Senegal	2
TN - Tunisia	2
A2 - ???statistics.table.value.countryCode.A2???	1
AL - Albania	1
AO - Angola	1
BE - Belgio	1
CR - Costa Rica	1
GR - Grecia	1
HU - Ungheria	1
IL - Israele	1
KH - Cambogia	1
LB - Libano	1
LU - Lussemburgo	1
MD - Moldavia	1
MY - Malesia	1
PE - Perù	1
SA - Arabia Saudita	1
SE - Svezia	1
TH - Thailandia	1
TZ - Tanzania	1
UA - Ucraina	1
ZM - Zambia	1
Totale	1.359

Nome	#
How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population	263
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists	136
Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study	129
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience	128
Influence of tetrathiafulvalene (TTF) and derivatives on redox state and cell viability of human endothelial cells	119
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era?	115
Vaccination and anti-SARS-CoV-2 treatment reduce disease progression: a real-life experience	113
Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression	106
Living with HIV and Getting Vaccinated: A Narrative Review	105
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort	87
Efficacy and Safety of Ceftazidime–Avibactam Alone versus Ceftazidime–Avibactam Plus Fosfomycin for the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Multicentric Retrospective Study from the SUSANA Cohort	76
Totale	1.377

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	2	0	0	0	0	0	0	0	0	0	0	0	2
2022/2023	72	1	9	2	8	6	17	3	6	6	1	8	5
2023/2024	47	6	4	2	3	20	1	3	0	1	0	2	5
2024/2025	579	7	0	28	10	10	43	76	108	162	99	27	9
2025/2026	677	36	170	59	123	95	34	104	13	12	31	0	0
Totale													1.377